Pivoting to a High Quality Growth of Clinical Trials in China PharmaDJ x L.E.K. Clinical Development Report

Slide locked Sign in to view

Slide schematic 7/10

callout 0/1 chart 2/2 disclaimer 1/1 list 2/2 metric 0/1 quote 1/2 title 1/1

3 without position callout 1 · metric 1 · quote 1

calloutmetric · primaryquote

Components 10

callout bar-stacked bar-stacked disclaimer bullet bullet primary testimonial quote headline

Tools 2

Chart Selection Guide slide · 70%

chart/bar-stacked: Number of newly started clinical trials by trial phase (China)

List presentation slide · 80%

list/bullet: Strong growth of trial number in China has been fueled particularly by development of innovative drugs.

Metrics 1

CAGR growth_rate · 47%

Accelerated innovative drug developed: China has witnessed a strong growth of early-phase clinical trials, quickly catching up with global innovation capability

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide uses stacked bar charts to show the composition of clinical trials by phase (I, II, III) for China and the US.